We are live on ! Find out more
HURA

TuHURA Biosciences
HURA

89 hedge funds and large institutions have $16.9M invested in TuHURA Biosciences in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 37 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 5

311% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 9

246% more capital invested

Capital invested by funds: $4.88M → $16.9M (+$12M)

37% more funds holding

Funds holding: 65 → 89 (+24)

Holders
89
Holders Change
+24
Holders Change %
+36.92%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
37
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$1.08M
2
AQR Capital Management
AQR Capital Management
Connecticut
+$724K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$398K
4
State Street
State Street
Massachusetts
+$274K
5
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
+$172K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$187K
2
Barclays
Barclays
United Kingdom
-$53.2K
3
Wells Fargo
Wells Fargo
California
-$25.4K
4
CWP
Cyndeo Wealth Partners
Florida
-$25K
5
HWMG
Hurlow Wealth Management Group
Indiana
-$23.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$4.39M +$1.08M +883,892 +56%
VCM
2
Vanguard Capital Management
Pennsylvania
$3.71M +$2.54M +2,074,228 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.77M +$398K +324,441 +49%
AQR Capital Management
4
AQR Capital Management
Connecticut
$1.09M +$724K +590,670 +3,580%
State Street
5
State Street
Massachusetts
$918K +$274K +223,780 +77%
Northern Trust
6
Northern Trust
Illinois
$534K +$131K +106,551 +56%
VFT
7
Vanguard Fiduciary Trust
Pennsylvania
$514K +$352K +287,133 New
VPM
8
Vanguard Portfolio Management
Pennsylvania
$454K +$311K +253,641 New
Bank of New York Mellon
9
Bank of New York Mellon
New York
$379K +$1.43K +1,166 +0.6%
AWM
10
Apollon Wealth Management
South Carolina
$283K +$29.1K +23,717 +18%
Cetera Investment Advisers
11
Cetera Investment Advisers
Illinois
$251K +$172K +140,244 New
SEM
12
Suncoast Equity Management
Florida
$187K – – –
Charles Schwab
13
Charles Schwab
California
$177K +$20.9K +17,017 +21%
WP
14
WealthShield Partners
North Carolina
$164K +$112K +91,530 New
IC
15
IEQ Capital
California
$146K +$99.7K +81,316 New
Bank of America
16
Bank of America
North Carolina
$140K +$18.5K +15,135 +24%
Deutsche Bank
17
Deutsche Bank
Germany
$129K -$9.63K -7,856 -10%
Goldman Sachs
18
Goldman Sachs
New York
$126K +$38.2K +31,153 +80%
GCP
19
GSA Capital Partners
United Kingdom
$112K +$76.6K +62,538 New
UBS Group
20
UBS Group
Switzerland
$111K +$41.6K +33,935 +121%
I
21
INVST
Indiana
$76.1K – – –
Carson Wealth (CWM LLC)
22
Carson Wealth (CWM LLC)
Nebraska
$74.8K +$49.8K +40,648 +3,642%
CAM
23
Cresset Asset Management
Illinois
$67.5K +$46.2K +37,736 New
GWM
24
Greenline Wealth Management
Florida
$66.1K +$45.3K +36,927 New
N
25
Nuveen
North Carolina
$60.1K – – –
1
2 3 4

HURA Hedge Fund Activity: Q1 2026 in Review

89 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2026, worth a combined $16.9M — up 246% from $4.88M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new HURA positions and 5 closed out — a net gain of 25 holders — while 37 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $1.08M. The largest seller was Morgan Stanley, cutting an estimated $187K.

  • 89 institutional investors held TuHURA Biosciences (HURA) as of Q1 2026, up from 65 in Q4 2025.
  • Funds reported $16.9M of TuHURA Biosciences stock for Q1 2026, up 246% quarter-over-quarter.
  • 30 funds opened new TuHURA Biosciences positions in Q1 2026 and 5 closed out, a net change of +25 holders.
  • The largest TuHURA Biosciences buyer in Q1 2026 was BlackRock, an estimated $1.08M added.
  • The largest TuHURA Biosciences seller in Q1 2026 was Morgan Stanley, an estimated $187K sold.

Based on aggregated 13F filings for Q1 2026.